Language

  • English
  • Français
  • About Us

    Together, we’re making precision oncology accessible

    At Imagia Canexia Health, we empower our partners with end-to-end solutions that allow you to deploy cancer genomic tests within your own facility.

    About Us

    • Leadership Team
    • Careers

      Together, we’re making precision oncology accessible

      At Imagia Canexia Health, we empower our partners with end-to-end solutions that allow cancer genomic assays to be deployed locally

      Current Job Postings

    • Contact Us

      Together, we’re making precision oncology accessible

      At Imagia Canexia Health, we empower our partners with end-to-end solutions that allow you to deploy cancer genomic assays within your own facility.

      Contact Us

    • Privacy Policy
  • Solutions

    Helping you deliver precision care

    Imagia Canexia Health makes high-quality cancer genomic information accessible and affordable with our software platform, tissue and liquid assays, and expert clinical services.

    About Our Solutions

    • Clinical Services

      Your partner in precision oncology

      Imagia Canexia Clinical Services supports laboratories with bringing precision oncology programs in-house and the implementation and maintenance of clinical NGS -based assays.

      Imagia Canexia Clinical Services

    • Insights Platform

      Molecular oncology, streamlined

      Imagia Canexia Health Insights Platform is an end-to-end cloud-based precision oncology system for the analysis, interpretation, and reporting on NGS panels.

      About Imagia Canexia Health Insights Platform

    • Tissue

      Detecting Genomic Aberrations in Solid Tumor Tissue

      Learn more about Tissue

      • Find It®

        Detect mutations in solid tumor tissue

        Tailor treatment decisions based on somatic mutations in your patient’s tumor.

        About Find It

      • Fusions

        Detect known and novel fusions in solid tumors

        Rapid, cost-effective, and clinically actionable, Fusions allows you the flexibility to isolate and interrogate only relevant fusions.

        About Fusions

    • Plasma (Follow It®)

      Detect Mutations in Plasma

      A minimally invasive assay for biopsy, Follow It can also be used to monitor cancer progression or detect treatment resistance.

      About Follow It

  • Imagia Canexia AI
  • Partnerships
    • Project ACTT
  • Resources
    • All Resources
    • Publications
    • Events
  • Contact Us

Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic

Head Office
6650 Rue Saint-Urbain #100
Montreal, Quebec H2S 3G9

Vancouver Office
Suite #1 – 3661 4th Ave W
Vancouver, BC  V6R 1P2

Laboratory
Suite #204 Donald Rix Building
2389 Health Sciences Mall
Vancouver, BC  V6T 1Z3

  • About Us

    Together, we’re making precision oncology accessible

    At Imagia Canexia Health, we empower our partners with end-to-end solutions that allow you to deploy cancer genomic tests within your own facility.

    About Us

  • Solutions

    Helping you deliver precision care

    Imagia Canexia Health makes high-quality cancer genomic information accessible and affordable with our software platform, tissue and liquid assays, and expert clinical services.

    About Our Solutions

  • Imagia Canexia AI
  • Partnerships
  • Resources
  • Contact Us
  • Solutions

    Helping you deliver precision care

    Imagia Canexia Health makes high-quality cancer genomic information accessible and affordable with our software platform, tissue and liquid assays, and expert clinical services.

    About Our Solutions

  • Find It®

    Detect mutations in solid tumor tissue

    Tailor treatment decisions based on somatic mutations in your patient’s tumor.

    About Find It

  • Follow It®

    Detect Mutations in Plasma

    A minimally invasive assay for biopsy, Follow It can also be used to monitor cancer progression or detect treatment resistance.

    About Follow It

  • Fusions

    Detect known and novel fusions in solid tumors

    Rapid, cost-effective, and clinically actionable, Fusions allows you the flexibility to isolate and interrogate only relevant fusions.

    About Fusions

  • Imagia Canexia Insights Platform

    Molecular oncology, streamlined

    Imagia Canexia Health Insights Platform is an end-to-end cloud-based precision oncology system for the analysis, interpretation, and reporting on NGS panels.

    About Imagia Canexia Health Insights Platform

  • Clinical Services

    Your partner in precision oncology

    Imagia Canexia Clinical Services supports laboratories with bringing precision oncology programs in-house and the implementation and maintenance of clinical NGS -based assays.

    Imagia Canexia Clinical Services

Stay Connected

Don’t miss out on news, webinars, and other resources from Imagia Canexia Health. Subscribe to our mailing list to stay up to date on the latest. You can opt-out at any time.

ionicons-v5_logos ionicons-v5_logos

Canexia Health products were developed in a CAP, CLIA, DAP, and CDPH accredited/licensed laboratory. These products are intended for research use only (RUO) and are not intended for the diagnosis, prevention or treatment of a disease.

© Imagia Canexia Health 2022

  • Privacy Policy

Brand & Website Design by Massive Media